BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 7051958)

  • 1. Levamisole: a double blind immunological study.
    Webster DJ; Whitehead RH; Richardson G; Hughes LE
    Anticancer Res; 1982; 2(1-2):29-32. PubMed ID: 7051958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunotherapy of cancer using levamisole, immunologic control of the post-surgical patient and graphic follow-up].
    de Carli HO; Llargues JM
    Rev Esp Oncol; 1980; 27(1):67-80. PubMed ID: 7209109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary report of the use of levamisole in the treatment of bladder cancer.
    Smith RB; deKernion J; Lincoln B; Skinner DG; Kaufman JJ
    Cancer Treat Rep; 1978 Nov; 62(11):1709-14. PubMed ID: 365325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant levamisole in the treatment of patients with resectable lung cancer.
    Amery WK
    Ann Clin Res; 1980; 12 Suppl 27():1-83. PubMed ID: 6999969
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of levamisole treatment in cancer patients.
    Amery WK; Verhaegen H
    J Rheumatol Suppl; 1978; 4():123-35. PubMed ID: 366137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levamisole treatment in ulcus cruris. A double-blind placebo-controlled study.
    Morias J; Peremans W; Campaert H; Mertens RL
    Arzneimittelforschung; 1979; 29(7):1050-2. PubMed ID: 387047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double blind randomized prospective trial of levamisole/placebo in stage I cutaneous malignant melanoma.
    Loutfi A; Shakr A; Jerry M; Hanley J; Shibata HR
    Clin Invest Med; 1987 Jul; 10(4):325-8. PubMed ID: 3308241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levamisole therapy in chronic hepatitis--results of a multicentric double blind trial.
    Nilius R; Schentke U; Otto L; Teichmann W; Zipprich B; Schmidt W; Brügmann E; Busse HJ
    Hepatogastroenterology; 1983 Jun; 30(3):90-2. PubMed ID: 6350136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant immunotherapy of carcinoma colli with levamisole. Prevention of immunological depression following surgical therapy and radiotherapy.
    Shiraki S; Mori H; Kadomoto N; Nakano T; Yamada Y; Noda K
    Int J Immunopharmacol; 1982; 4(1):73-80. PubMed ID: 7085141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind placebo-controlled evaluation of levamisole in chronic rheumatoid arthritis.
    Franchimont P; Heynen G; Berghs H; Remans J; Vroninks P
    Scand J Rheumatol; 1979; 8(1):43-8. PubMed ID: 373088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levamisole: adjunctive therapy in steroid dependent minimal change nephrotic children.
    Donia AF; Amer GM; Ahmed HA; Gazareen SH; Moustafa FE; Shoeib AA; Ismail AM; Khamis S; Sobh MA
    Pediatr Nephrol; 2002 May; 17(5):355-8. PubMed ID: 12042893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Controlled trial of levamisole in rheumatoid arthritis. Clinical and immunological study of 22 cases (author's transl)].
    Rondier J; Cayla J; Tron F; Roger M; Bach JF
    Nouv Presse Med; 1978 Oct; 7(34):3023-7, 3029-30. PubMed ID: 364409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Final results of a multicenter placebo-controlled levamisole study of resectable lung cancer.
    Amery WK
    Cancer Treat Rep; 1978 Nov; 62(11):1677-83. PubMed ID: 365323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levamisole versus placebo as an adjunct to primary therapy of laryngopharyngeal epidermoid carcinoma. Evaluation of the immune status.
    Mussche RA; Plum J; de Smedt M; Kluyskens P
    Acta Otorhinolaryngol Belg; 1977; 31(6):566-77. PubMed ID: 339662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of levamisole in atopic dermatitis: a prospective study.
    Alomar A; Giménez-Camarasa JM; de Moragas JM
    Arch Dermatol; 1978 Sep; 114(9):1316-9. PubMed ID: 356739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of levamisole in patients with squamous cancer of the head and neck: a preliminary report.
    Wanebo HJ; Hilal EY; Pinsky CM; Strong EW; Mike V; Hirshaut Y; Oettgen HF
    Cancer Treat Rep; 1978 Nov; 62(11):1663-9. PubMed ID: 365322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once weekly administration of levamisole in rheumatoid arthritis.
    Fostiropoulos GA; Zissis NP; Marketos G
    Clin Invest Med; 1982; 5(4):255-8. PubMed ID: 6218948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunocompetence and its modification after BCG immunotherapy in patients with colon carcinoma.
    Pacheco-Rupil B; Depiante M; Yantorno C; Nuñez P; Casadio B
    Acta Gastroenterol Latinoam; 1980; 10(4):277-82. PubMed ID: 7270013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of rheumatoid arthritis by levamisole. First results].
    Sany J; Morlock G; Clot J; Serre H
    Rev Rhum Mal Osteoartic; 1977 Mar; 44(3):143-53. PubMed ID: 322247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.